Webinar: Extra-Rendite mit Optionen für Erfahrene Börsenanleger

Biocartis Group Aktie

Watchlist 8XB WKN A14R82 ISIN BE0974281132

Was macht Biocartis Group?

Unternehmensprofil
Unternehmensprofil

Biocartis Group NV engages in the development of personalized medicine for patients around the world. It also focuses on developing and commercializing oncology tests. The company was founded by Philippe Renaud, Nader Donzel, and Rudi Pauwels in July 2007 and is headquartered in Mechelen, Belgium.

Chart der Biocartis Group Aktie

Charttool öffnen

Aktuelle Nachrichten zu Biocartis Group

Das berichten andere über Biocartis Group